Bayer and Monsanto announced that they signed a definitive merger agreement under which Bayer will acquire Monsanto for $128 per share in an all-cash transaction. Monsanto's Board of Directors, Bayer's Board of Management and Bayer's Supervisory Board have unanimously approved the agreement. The offer represents a premium of 44% to Monsanto's closing share price on May 9, 2016, the day before Bayer's first written proposal to Monsanto.
Morrow Sodali is serving as the proxy solicitor for Monsanto.
Related News
Shareholder activism: the reality of an escalating threat in Spain
08 June 2025
Sodali & Co improves ranking across the board as UK Financial PR adviser to FTSE companies
03 June 2025
Hayden Mattiske Joins Judging Panel for the 75th Australasian Reporting Awards
05 May 2025
CSRD and Omnibus: Implications of Recent Changes on Corporate Disclosure
24 April 2025
Media enquiries
To contact our global experts for comments please get in touch below.
Contact us chevron_right